HIV and Non‐ HIV Patients Have Similar Rates of Neoplastic Findings on Screening Colonoscopy Within a Predominantly African American Cohort
Cancer Medicine · 2025
DOI: 10.1002/cam4.70811 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Pooja Mude und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA. Hauptthemen laut MEDLINE: Colonoscopy, HIV Infections, Black or African American, Early Detection of Cancer. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
With the reduction in human immunodeficiency virus (HIV)–related mortality secondary to antiretroviral therapy, chronic medical conditions and age‐related cancers account for a larger proportion of mortality among those with HIV. Cancer risk overall remains elevated in HIV patients, and cancer screening data in this population is limited. The primary study aim was to determine whether screening colonoscopy findings differed between HIV and non‐HIV patients.
Methods
A retrospective review of adults with/without HIV undergoing screening colonoscopy between February 2015 and September 2022 was performed. HIV patients were matched with non‐HIV patients by sex, race, and age, undergoing screening colonoscopy within six business days of their matched patients. Demographic data included age, race, sex, family history of colorectal cancer (CRC), smoking status, alcohol use, along with endoscopic and histologic findings that were compared between the matched pairs.
Results
Ninety matched pairs of HIV and non‐HIV patients undergoing screening colonoscopy comprised the study population. The study group was 78.9% African American, 55.6% male, with a mean age of 59.0 years in HIV patients and 54.9 years in non‐HIV patients. Procedure indication was average risk screening in 91.1% of patients. No statistically significant differences in screening colonoscopy findings or polyp histology were observed between HIV and non‐HIV patients.
Discussion
Similar rates of polyps were found at screening colonoscopy regardless of HIV status. CRC screening recommendations are appropriate for the HIV patient population without limitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
- Department of Medicine, Memorial Health University Medical Center-HCA, Savannah, Georgia, USA.
- Department of Medicine, University of Florida Health Science Center, Jacksonville, Florida, USA.
- Division of Gastroenterology & Hepatology, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.
- Gastroenterology Section, VA Loma Linda Healthcare System, Loma Linda, California, USA.
- Division of Gastroenterology & Hepatology, Prisma Health-Midlands, Columbia, South Carolina, USA.
ORCID-Profile: Alexandra E Thomson, Lavannya Atri, John Erikson L Yap, Kenneth J Vega
Zitieren
APA
Mude, P., Thomson, A. E., Atri, L., Newman, S., Palacio, C., Yap, J. E. L., Jackson, C. S., & Vega, K. J. (2025). HIV and Non‐ HIV Patients Have Similar Rates of Neoplastic Findings on Screening Colonoscopy Within a Predominantly African American Cohort. Cancer Medicine. https://doi.org/10.1002/cam4.70811
Vancouver
Mude P, Thomson AE, Atri L, Newman S, Palacio C, Yap JEL, et al. HIV and Non‐ HIV Patients Have Similar Rates of Neoplastic Findings on Screening Colonoscopy Within a Predominantly African American Cohort. Cancer Medicine. 2025. doi:10.1002/cam4.70811
BibTeX
@article{Mude2025,
author = {Mude, Pooja and Thomson, Alexandra E and Atri, Lavannya and Newman, Samantha and Palacio, Carlos and Yap, John Erikson L and Jackson, Christian S and Vega, Kenneth J},
title = {HIV and Non‐ HIV Patients Have Similar Rates of Neoplastic Findings on Screening Colonoscopy Within a Predominantly African American Cohort},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70811}
}
EUVIMED